In LUME-Lung 1, adverse events† with VARGATEF® plus docetaxel were generally manageable1
The most common adverse events with VARGATEF® + docetaxel were:
AEs reported in ≥ 10% of adenocarcinoma patients in LUME-lung 12
AE = adverse event;
ALT = alanine aminotransferase;
AST = aspartate aminotransferase;
WBC = white blood cell
†Adverse events were classified according to Common Terminology Criteria for Adverse Events version 3.0.